Daptomycin is a novel lipopeptide antibiotic agent approved for the treatment of gram-positive life-threatening infections. Here we report, for the first time, the isolation of a highly daptomycin-resistant strain of Corynebacterium jeikeium causing a life-threatening infection in a neutropenic patient undergoing cord blood transplantation for secondary acute myeloid leukemia.
CASE REPORTA 46-year-old man with an uneventful past medical history was diagnosed with acute lymphoblastic leukemia in early 2007. He received a first allogeneic stem cell transplant from a matched unrelated donor after successful induction and consolidation therapy. Early after transplantation, he presented with secondary acute myeloid leukemia and was induced with cyclophosphamide and clofarabine, leading to prolonged neutropenia. Without neutrophil recovery, he proceeded to a second allogeneic stem cell transplantation using a double cord blood source. Since vancomycin-resistant Enterococcus faecium (VRE) was detected in earlier stool samples of this patient, two further stool samples were taken after admission to the transplant unit and the presence of VRE was confirmed. Due to this finding, the prior systemic antibiotic chemotherapy and persistent neutropenia, and continuing fever, we treated the patient with a combination of ceftazidime and tigecycline (Fig. 1).After conditioning chemotherapy was initiated, the antibiotic treatment was changed to meropenem and fosfomycin due to recurring febrile temperatures. While fever continued for 2 days, three blood cultures taken on day Ϫ6 (before the second transplant) were found to be positive for vancomycin-sensitive E. faecium and Staphylococcus haemolyticus. As both isolates showed susceptibility to daptomycin, the antibiotic regimen was changed to daptomycin and ceftazidime (Fig. 1). The patient recovered from febrile temperatures and received a double cord blood allograft on day 0 (8 January 2008). Blood cultures taken from each of the four central venous catheter lines on days Ϫ1 and ϩ1 remained sterile. The clinical course was again complicated on day ϩ3 by increasing C-reactive protein (CRP) levels and fever. The antibiotic regimen was therefore changed to meropenem, fosfomycin, and ciprofloxacin, leading to a short-term decrease of CRP levels and clinical symptoms.Due to recurrent febrile temperatures, the past infectious history, and positive results for gram-positive rods in two out of four blood cultures taken on day ϩ5, fosfomycin was substituted for daptomycin on day ϩ8. Four further aerobic and anaerobic blood cultures, taken on day ϩ8 and incubated at 37°C in a BacT/Alert 3D instrument (bioMérieux, Marcy-l'-Etoile, France), were found to be positive for gram-positive rods after 24 h of cultivation. Subculture testing for another 24 h at 37°C in a 5% CO 2 -enriched atmosphere revealed small, gray, catalase-positive colonies on chocolate and blood agar. The organism was subsequently identified as Corynebacterium jeikeium (P ϭ 0.963) by using an API Coryne V3.0 kit (bioMérieux, ...